article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

Forbion raises $1.47bn for two life sciences-focused funds

Pharmaceutical Technology

European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The funds were created to cater to the needs of two distinct segments of the market. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs

Pharma Mirror

by Nataliya Andreychuk, Co-founder and CEO of Viseven Many pharma brands still shy away from marketing directly to patients, depending on conversion through healthcare providers (HCPs). And it is not hard to see why.

article thumbnail

Life sciences leaders invest in process mining to accelerate digital transformation

Bio Pharma Dive

Research from Everest Group shows how life sciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.

article thumbnail

The next frontier: How to use AI-powered analytics for life sciences marketing

pharmaphorum

Discover how AI-powered analytics are revolutionising life sciences marketing. Learn how to leverage these cutting-edge technologies to drive insights and success in the industry.

article thumbnail

“In AI We Trust”: What Salesforce 2023 Offered Life Sciences Marketers

Intouch Solutions

This year’s Dreamforce conference – the annual gathering for Salesforce, one of the main providers in commercial marketing and sales technology for the Health & Life Science (HLS) industry – was bigger and more innovative than ever. But what news will matter most for health & life sciences companies?

article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

XtalPi has entered a strategic partnership with CK Life Sciences for artificial intelligence (AI)-driven tumour vaccine research and development (R&D). The aim of the alliance is to bring to market precision therapy for patients globally. In September 2020, the company raised funds worth $318.8m